Home › Compare › MEDT vs DIVO

MEDT vs DIVO: Dividend Comparison 2026

MEDT yields 20000000.00% · DIVO yields 6.49%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MEDT wins by $4.875981653489057e+49M in total portfolio value
10 years
MEDT
MEDT
● Live price
20000000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.875981653489057e+49M
Annual income
$48,759,336,949,911,260,000,000,000,000,000,000,000,000,000,000,000,000,000.00
Full MEDT calculator →
DIVO
DIVO
● Live price
6.49%
Share price
$44.85
Annual div
$2.91
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$981.68
Full DIVO calculator →

Portfolio growth — MEDT vs DIVO

📍 MEDT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMEDTDIVO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MEDT + DIVO cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
MEDT pays
DIVO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MEDT
Annual income on $10K today (after 15% tax)
$1,700,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$41,445,436,407,424,570,000,000,000,000,000,000,000,000,000,000,000,000,000.00/yr
DIVO
Annual income on $10K today (after 15% tax)
$552.00/yr
After 10yr DRIP, annual income (after tax)
$834.43/yr
At 15% tax rate, MEDT beats the other by $41,445,436,407,424,570,000,000,000,000,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MEDT + DIVO for your $10,000?

MEDT: 50%DIVO: 50%
100% DIVO50/50100% MEDT
Portfolio after 10yr
$2.4379908267445285e+49M
Annual income
$24,379,668,474,955,630,000,000,000,000,000,000,000,000,000,000,000,000,000.00/yr
Blended yield
100.00%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MEDT buys
0
DIVO buys
0
No recent congressional trades found for MEDT or DIVO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMEDTDIVO
Forward yield20000000.00% ✓6.49%
Annual dividend / share$2.00$2.91 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$4.875981653489057e+49M$30.7K ✓
Annual income after 10y$48,759,336,949,911,260,000,000,000,000,000,000,000,000,000,000,000,000,000.00 ✓$981.68
Total dividends collected$4.875978515990276e+49M$8.2K ✓
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: MEDT vs DIVO ($10,000, DRIP)

YearMEDT PortfolioMEDT Income/yrDIVO PortfolioDIVO Income/yrGap
1← crossover$2,000,010,700$2,000,000,000.00$11,349$649.42+$2000.00M → MEDT
2$373,835,915,712,384$373,833,775,700,934.50$12,833$688.83+$373835915.70M → MEDT
3$65,304,953,364,964,970,000$65,304,553,360,535,160,000.00$14,459$727.90+$65304953364964.95M → MEDT
4$10,661,728,832,755,500,000,000,000$10,661,658,956,455,399,000,000,000.00$16,238$766.49+$10661728832755499008.00M → MEDT
5$1,626,767,783,781,495,000,000,000,000,000$1,626,756,375,731,643,800,000,000,000,000.00$18,179$804.47+$1.626767783781495e+24M → MEDT
6$231,974,330,054,625,100,000,000,000,000,000,000$231,972,589,413,096,470,000,000,000,000,000,000.00$20,293$841.71+$2.319743300546251e+29M → MEDT
7$30,915,106,403,922,057,000,000,000,000,000,000,000,000$30,914,858,191,388,900,000,000,000,000,000,000,000,000.00$22,591$878.14+$3.0915106403922057e+34M → MEDT
8$3,850,507,985,839,278,000,000,000,000,000,000,000,000,000,000$3,850,474,906,675,425,000,000,000,000,000,000,000,000,000,000.00$25,087$913.65+$3.8505079858392777e+39M → MEDT
9$448,210,261,035,314,200,000,000,000,000,000,000,000,000,000,000,000$448,206,140,991,769,400,000,000,000,000,000,000,000,000,000,000,000.00$27,791$948.18+$4.4821026103531426e+44M → MEDT
10$48,759,816,534,890,570,000,000,000,000,000,000,000,000,000,000,000,000,000$48,759,336,949,911,260,000,000,000,000,000,000,000,000,000,000,000,000,000.00$30,718$981.68+$4.875981653489057e+49M → MEDT

MEDT vs DIVO: Complete Analysis 2026

MEDT — Stock

MediaTechnics Corporation operates as a developer of advertising Websites and applications for marijuana industry. It develops BlazeNow, a suite of mobile applications for the iOS and Android operating systems; and BlazeNow.com, a Website to provide product and location advertising services, as well as a mutually consumer review system for dispensaries, doctors, and delivery services in the legal Cannabis industry. The company also offers professional consulting services to legal recreational and medical cannabis markets; and products packaging and private labeling services. In addition, it engages in researching and testing nutrients to promote flower yields and eliminating crop-damaging pests; and indoor cultivation technologies, including LED lights and environmental control devices, as well as mining, analyzing, and supplying sales and product data information. The company was incorporated in 1987 and is headquartered in Las Vegas, Nevada.

Full MEDT Calculator →

DIVO — ETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →
📬

Get this MEDT vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MEDT vs SCHDMEDT vs JEPIMEDT vs OMEDT vs KOMEDT vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.